With the increased CD4+ Tregs and effector CD4+ T cells in FLC tumor, we hypothesized that IL-10 blockade could work in FLC in conjunction with blockade of PD-1 to reactive effector CD8+ and CD4+ T cells63. The gene discussed is PDCD1; the disease is fibrolamellar hepatocellular carcinoma.